tiprankstipranks
Trending News
More News >
Enzo Biochem, Inc. (ENZB)
:ENZB
Advertisement

Enzo Biochem (ENZB) Price & Analysis

Compare
189 Followers

ENZB Stock Chart & Stats


Financials

Ownership Overview

12.07%4.26%13.44%70.23%
12.07%
Insiders
4.26%
Mutual Funds
13.44% Other Institutional Investors
70.23% Public Companies and
Individual Investors

ENZB FAQ

What was Enzo Biochem, Inc.’s price range in the past 12 months?
Enzo Biochem, Inc. lowest stock price was $0.25 and its highest was $1.19 in the past 12 months.
    What is Enzo Biochem, Inc.’s market cap?
    Enzo Biochem, Inc.’s market cap is $35.76M.
      When is Enzo Biochem, Inc.’s upcoming earnings report date?
      Enzo Biochem, Inc.’s upcoming earnings report date is Oct 21, 2025 which is in 88 days.
        How were Enzo Biochem, Inc.’s earnings last quarter?
        Enzo Biochem, Inc. released its earnings results on Jun 16, 2025. The company reported -$0.053 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.053.
          Is Enzo Biochem, Inc. overvalued?
          According to Wall Street analysts Enzo Biochem, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Enzo Biochem, Inc. pay dividends?
            Enzo Biochem, Inc. pays a Notavailable dividend of $0.1 which represents an annual dividend yield of N/A. See more information on Enzo Biochem, Inc. dividends here
              What is Enzo Biochem, Inc.’s EPS estimate?
              Enzo Biochem, Inc.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Enzo Biochem, Inc. have?
              Enzo Biochem, Inc. has 52,432,130 shares outstanding.
                What happened to Enzo Biochem, Inc.’s price movement after its last earnings report?
                Enzo Biochem, Inc. reported an EPS of -$0.053 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.263%.
                  Which hedge fund is a major shareholder of Enzo Biochem, Inc.?
                  Currently, no hedge funds are holding shares in ENZB

                  Company Description

                  Enzo Biochem, Inc.

                  Enzo Biochem, Inc. (ENZB) is a life sciences and biotechnology company specializing in the development, manufacture, and sale of innovative products and technologies for research, diagnostics, and therapeutics. The company operates primarily through two segments: Enzo Clinical Labs and Enzo Life Sciences. Enzo Clinical Labs provides a full range of clinical laboratory and pathology services, while Enzo Life Sciences develops, manufactures, and markets reagents, assays, and systems used in medical research and drug development.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  IGC Pharma
                  Tvardi Therapeutics
                  Enlivex
                  BioAtla
                  Neurosense Therapeutics Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis